Navigation Links
Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine
Date:5/5/2011

HOPKINTON, Mass., May 5, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life sciences research for personalized medicine, will be hosting its Caliper Owners Group (COG 2011) meeting on May 17th and 18th.  This annual event brings together global thought-leaders in research, drug discovery, and diagnostics to discuss the technologies and discoveries that are transforming the detection and treatment of disease, and making personalized medicine a reality.

"COG 2011 will be a landmark event for Caliper," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences.  "The presentations and groundbreaking research that will be shared at this event will highlight how Caliper technologies are increasingly impacting the development of therapeutics and diagnostics that will revolutionize medicine and enable personalized healthcare."

Over 375 customers and investors are expected to attend the meeting, which will be held at Caliper's Hopkinton headquarters. The event will feature keynote presentations from Dr. Dennis Ausiello, Physician-in-Chief, Department of Medicine, Massachusetts General Hospital, Jackson Professor of Clinical Medicine, Harvard Medical School, Chief Scientific Officer, Partners Healthcare; Dr. Go van Dam, Associate Professor at University Medical Center Groningen; Dr. Stephan Schuster, Professor of Biochemistry and Molecular Biology at Pennsylvania State University; and Kevin Hrusovsky, President and CEO of Caliper Life Sciences.  Additionally, the event will feature more than 40 presentations from researchers representing life sciences companies and institutions, including Pfizer, Novartis, Bristol Meyers Squibb, University of Washington Genome Institute, University of Miami Hussman Institute for Human Genomics, University of Sherbrooke, Children's Mercy Hospital, EMD Serono, Cell Signaling Technology, Yale University, Transgenomic, Access Genetics, Roche NimbleGen, NuGEN Technologies, and the National Institutes of Health.

To view the complete agenda or register to attend, please visit Caliper's website at: http://www.caliperls.com/products/cog2011.php

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently.  Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease.  Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper is a registered trademark of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
2. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
3. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
6. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
7. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
8. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
9. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
11. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech Ltd. ... leading provider of biopharmaceutical products in China ... its board of directors received on February 4, 2016 ... from a consortium comprised of PKU V-Ming ( ... Co., Ltd., CICC Qianhai Development ( Shenzhen ...
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
Breaking Biology Technology:
(Date:1/20/2016)... 20, 2016 A market that just keeps ... from the explosion in genomics knowledge. Learn all about ... A range of dynamic trends are pushing market growth ... medicine - pharmacogenomics - pathogen evolution - next generation ... - greater understanding of the role of genetic material ...
(Date:1/15/2016)... SAN JUAN, Puerto Rico , Jan. 15, 2016 ... forcing companies big and small to find new ways ... data driven culture. iOS and ... their device based on biometrics, transforming it into a ... can request that users swipe their fingerprint on their ...
(Date:1/11/2016)... -- higi, the leading retail and omni-channel community engagement platform ... mobile, today announced it has closed funding of ... --> --> The ... health platform – its network of health stations, ... services and programs to retail partners and healthcare ...
Breaking Biology News(10 mins):